BioCentury | Oct 6, 2020
Deals

Oct. 5 Quick Takes: BridgeBio reacquiring Eidos, Amgen KRAS data, after-hours tumbles for Iovance, Y-mAbs and more

...million) in a series A round led by Oriza Seed, with participation by Hygeia Capital, Ming Bioventures...
BioCentury | Aug 11, 2020
Finance

Aug. 10 Quick Takes: Megarounds for Lepu, Dyne; plus CureVac’s IPO plans, top marks for Chinese biotech trio and more

...ABM Therapeutics Inc.’s financing, which saw participation by new investors Sinopharm Capital, Panlin Capital and Ming Bioventures...
BioCentury | Dec 28, 2019
Financial News

Elpiscience’s $100M series B provides path to IPO

...of global BD, told BioCentury. New investors Tencent, GTJA Investment Group, Dyee Capital, Oriza Holdings, Ming Bioventures...
Items per page:
1 - 3 of 3
BioCentury | Oct 6, 2020
Deals

Oct. 5 Quick Takes: BridgeBio reacquiring Eidos, Amgen KRAS data, after-hours tumbles for Iovance, Y-mAbs and more

...million) in a series A round led by Oriza Seed, with participation by Hygeia Capital, Ming Bioventures...
BioCentury | Aug 11, 2020
Finance

Aug. 10 Quick Takes: Megarounds for Lepu, Dyne; plus CureVac’s IPO plans, top marks for Chinese biotech trio and more

...ABM Therapeutics Inc.’s financing, which saw participation by new investors Sinopharm Capital, Panlin Capital and Ming Bioventures...
BioCentury | Dec 28, 2019
Financial News

Elpiscience’s $100M series B provides path to IPO

...of global BD, told BioCentury. New investors Tencent, GTJA Investment Group, Dyee Capital, Oriza Holdings, Ming Bioventures...
Items per page:
1 - 3 of 3